| Primary and secondary immunodeficiency diseases in oncohaematology: warning signs, diagnosis, and management S Sánchez-Ramón, A Bermúdez, LI González-Granado, ... Frontiers in immunology 10, 586, 2019 | 76 | 2019 |
| IVIg promote cross-tolerance against inflammatory stimuli in vitro and in vivo Á Domínguez-Soto, M Simón-Fuentes, M de Las Casas-Engel, ... The Journal of Immunology 201 (1), 41-52, 2018 | 22 | 2018 |
| Trained immunity based-vaccines as a prophylactic strategy in common variable immunodeficiency. A proof of concept study K Guevara-Hoyer, P Saz-Leal, CM Diez-Rivero, J Ochoa-Grullón, ... Biomedicines 8 (7), 203, 2020 | 21 | 2020 |
| Sublingual bacterial vaccination reduces recurrent infections in patients with autoimmune diseases under immunosuppressant treatment S Sánchez-Ramón, L Fernández-Paredes, P Saz-Leal, CM Diez-Rivero, ... Frontiers in Immunology 12, 675735, 2021 | 18 | 2021 |
| Evaluation of polysaccharide typhim vi antibody response as a predictor of humoral immunodeficiency in haematological malignancies J Ochoa-Grullón, CB Cuesta, CP López, AP Cortijo, AR de la Peña, ... Clinical Immunology 210, 108307, 2020 | 15 | 2020 |
| Measurement of typhim Vi IgG as a diagnostic tool to determine anti-polysaccharide antibody production deficiency in children K Guevara-Hoyer, C Gil, AR Parker, LJ Williams, C Orte, ... Frontiers in Immunology 10, 654, 2019 | 15 | 2019 |
| Serum free immunoglobulins light chains: a common feature of common variable immunodeficiency? K Guevara-Hoyer, J Ochoa-Grullón, M Fernández-Arquero, M Cárdenas, ... Frontiers in Immunology 11, 2004, 2020 | 12 | 2020 |
| Trained immunity-based vaccine in B cell hematological malignancies with recurrent infections: a new therapeutic approach J Ochoa-Grullon, C Benavente Cuesta, A Gonzalez Fernandez, ... Frontiers in Immunology 11, 611566, 2021 | 11 | 2021 |
| Variable immunodeficiency study: Evaluation of two European cohorts within a variety of clinical phenotypes K Guevara-Hoyer, J Vasconcelos, L Marques, AA Fernandes, ... Immunology letters 223, 78-88, 2020 | 10 | 2020 |
| Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies L García-Bravo, M Calle-Rubio, M Fernández-Arquero, KM Mohamed, ... Journal of Translational Autoimmunity 5, 100160, 2022 | 8 | 2022 |
| B‐cell haematological malignancies and SARS‐CoV‐2 infection: Could immunological interventions influence the outcome? J Ochoa‐Grullón, A Peña Cortijo, K Guevara‐Hoyer, C Jiménez García, ... EJHaem 2 (3), 503-507, 2021 | 4 | 2021 |
| Combined immune defect in b-cell lymphoproliferative disorders is associated with severe infection and cancer progression J Ochoa-Grullón, K Guevara-Hoyer, C Pérez López, R Pérez de Diego, ... Biomedicines 10 (8), 2020, 2022 | 2 | 2022 |
| Polybacterial mucosal stimulation in lymphoproliferative syndromes with recurrent infections: A new complementary strategy J Ochoa-Grullón, M Tejera-Alhambra, K Guevara, M Guzman-Fulgencio, ... ALLERGY 72, 195-196, 2017 | 2 | 2017 |
| Immunological Causes Associated to Foetal Death: An Update AC Boo, JO Grullón, P Coronado, MÁ Herráiz, S Sánchez-Ramón International Journal 2 (1), 51, 2014 | 2 | 2014 |
| Case Report: Novel STIM1 gain-of-function mutation in a patient with TAM/STRMK and immunological involvement E de la Fuente-Munoz, A Van Den Rym, B García-Solis, J Ochoa Grullón, ... Frontiers in Immunology 13, 917601, 2022 | 1 | 2022 |
| Study Of Anti-polysaccharide Antibody (Ab) Response Against S. Typhi For The Evaluation Of Patients With Recurrent Infection (RI) M Nunez Beltran, J Ochoa-Grullon, A Rodriguez, M Fernandez-Arquero, ... CLINICAL AND EXPERIMENTAL IMMUNOLOGY 182, 3-4, 2015 | 1 | 2015 |
| Increased myeloid-derived suppressor cells in women with recurrent miscarriage and recurrent implantation failure N Subhi-Issa Marin, R Gil Laborda, E De la Fuente Munoz, ... HUMAN REPRODUCTION 37, I390-I391, 2022 | | 2022 |
| Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression. Biomedicines 2022, 10, 2020 J Ochoa-Grullón, K Guevara-Hoyer, C Pérez López, R Pérez de Diego, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Protocolización del tratamiento con gammaglobulinas en el paciente con malignidad hematológica JL Ochoa Grullón Universidad Complutense de Madrid, 2021 | | 2021 |
| Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies J Ochoa-Grullón, C Orte, AR de la Peña, K Guevara-Hoyer, GC Torres, ... MethodsX 7, 100936, 2020 | | 2020 |
